Home/ Supplements/ Vitamin K/ Bone boost

Bone boost

product on market Capsule Ee Essential elements Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin D3 and K2 provide strong evidence for supporting calcium absorption and bone mineralization. Calcium hydroxyapatite and Cissus quadrangularis are included to support skeletal structure, though research on the latter is more limited. The ingredient profile maintains a high safety rating for general use.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Bone boost
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
30
Servings
Botanical with Nutrients
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mg
833.3× RDA — above typical dose 275 studies (A:9, B:175)
50 mcg (250% DV)
3.3× RDA — above typical dose (UL: 0.1 mg) 608 studies (A:16, B:251)
Cissus quadrangularis extract
350 mg
Cissus quadrangularis, Powder
350 mg
1400 mg (23.53% DV)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)

Other Ingredients

Cellulose Rice Flour Vegetable Oil, Powder Silica Maltodextrin
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, adults take one (1) capsule three times (3x) daily, with food, or as recommended by a healthcare professional.

Warnings & Precautions

Warning: Do not use if you are pregnant, attempting to become pregnant, or nursing. Consult a healthcare professional before using this or any other dietary supplement, especially if you have or suspect you may have any medical condition, or if you are taking anticoagulants, any other dietary supplement, prescription, or over-the-counter medications, as combining these products may cause side effects.

Discontinue use and immediately call a healthcare professional if you experience any adverse reactions. Do not exceed recommended serving. Read entire label prior to use.

Keep out of reach of individuals under the age of 18.

Do not use if safety seal is damaged or missing.

Formulation Notes

Bone health supplement

Gluten-free Soy-free Non-GMO Dairy-free Sugar-free Shellfish-free

2100 mg With Vitamins K2 & D3

Bone health & density support Encourages healthy bone formation Improves calcium absorption Helps strengthen bones

Preservative free

Additional Information

New

Store in a cool, dry place.

GMP Practice Good Manufacturing Made in the Unites States

Follow us: @EssentialElementsNutrition

Metadata

Product Details

UPC / SKUX002D1LXYH
DSLD Entry Date2022-11-22
Product TypeBotanical with Nutrients
FormCapsule
DSLD ID275154
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.